LRIG1 extracellular domain: Structure and function analysis

Journal of Molecular Biology

Volumn 427, Issue 10, 2015, Pages 1934-1948

  Xu, Yibin ^a   Soo, Priscilla ^a   Walker, Francesca ^a,b   Zhang, Hui Hua ^a   Redpath, Nicholas ^a,b   Tan, Chin Wee ^a,b   Nicola, Nicos A ^a,b   Adams, Timothy E ^c   Garrett, Thomas P ^a,b   Zhang, Jian Guo ^a,b   Burgess, Antony W ^a,b  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c CSIRO   (Australia)

Author keywords

EGFR inhibition; leucine rich repeat domain; LINGO 1; stem cell marker

Indexed keywords

EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; LEUCINE-RICH REPEAT PROTEINS; LIGAND; LRIG1 PROTEIN, HUMAN; MEMBRANE PROTEIN; PROTEIN;

CHEMICAL STRUCTURE; CHEMISTRY; COLON TUMOR; EXTRACELLULAR MATRIX; FLUORESCENCE MICROSCOPY; GENETIC PROCEDURES; HEK293 CELL LINE; HUMAN; METABOLISM; PATHOLOGY; PROTEIN CONFORMATION; PROTEIN TERTIARY STRUCTURE; STRUCTURE ACTIVITY RELATION; SURFACE PLASMON RESONANCE; TUMOR CELL CULTURE; X RAY CRYSTALLOGRAPHY;

BIOSENSING TECHNIQUES; COLONIC NEOPLASMS; CRYSTALLOGRAPHY, X-RAY; EXTRACELLULAR MATRIX; HEK293 CELLS; HUMANS; LIGANDS; MEMBRANE GLYCOPROTEINS; MICROSCOPY, FLUORESCENCE; MODELS, MOLECULAR; PROTEIN CONFORMATION; PROTEIN STRUCTURE, TERTIARY; PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; STRUCTURE-ACTIVITY RELATIONSHIP; SURFACE PLASMON RESONANCE; TUMOR CELLS, CULTURED;

EID: 84939968448     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2015.03.001     Document Type: Article

References (55)

1. P. Ordonez-Moran, and J. Huelsken Lrig1: a new master regulator of epithelial stem cells EMBO J 31 2012 2064 2066
2. A.E. Powell, Y. Wang, Y. Li, E.J. Poulin, A.L. Means, and M.K. Washington The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor Cell 149 2012 146 158
3. Z. Yan, J. Jiang, F. Li, W. Yang, G. Xie, and C. Zhou Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder cancer cells to cisplatin Oncol Rep 33 2015 1791 1798
4. V.W. Wong, D.E. Stange, M.E. Page, S. Buczacki, A. Wabik, and S. Itami Lrig1 controls intestinal stem-cell homeostasis by negative regulation of ErbB signalling Nat Cell Biol 14 2012 401 408
5. Y. Suzuki, N. Sato, M. Tohyama, A. Wanaka, and T. Takagi cDNA cloning of a novel membrane glycoprotein that is expressed specifically in glial cells in the mouse brain. LIG-1, a protein with leucine-rich repeats and immunoglobulin-like domains J Biol Chem 271 1996 22522 22527
6. M.B. Laederich, M. Funes-Duran, L. Yen, E. Ingalla, X. Wu, and K.L. Carraway The leucine-rich repeat protein LRIG1 is a negative regulator of ErbB family receptor tyrosine kinases J Biol Chem 279 2004 47050 47056
7. G. Gur, C. Rubin, M. Katz, I. Amit, A. Citri, and J. Nilsson LRIG1 restricts growth factor signaling by enhancing receptor ubiquitylation and degradation EMBO J 23 2004 3270 3281
8. M.A. Stutz, D.L. Shattuck, M.B. Laederich, K.L. Carraway, and C. Sweeney LRIG1 negatively regulates the oncogenic EGF receptor mutant EGFRvIII Oncogene 27 2008 5741 5752
9. S. Goldoni, R. Iozzo, P. Kay, S. Campbell, A. McQuillan, and C. Agnew A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity Oncogene 26 2007 368 381
10. M. Johansson, A. Oudin, K. Tiemann, A. Bernard, A. Golebiewska, and O. Keunen The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status Neuro Oncol 15 2013 1200 1211
11. F. Ledda, O. Bieraugel, S.S. Fard, M. Vilar, and G. Paratcha Lrig1 is an endogenous inhibitor of Ret receptor tyrosine kinase activation, downstream signaling, and biological responses to GDNF J Neurosci 28 2008 39 49
12. L. Lu, V.H. Teixeira, Z. Yuan, T.A. Graham, D. Endesfelder, and K. Kolluri LRIG1 regulates cadherin-dependent contact inhibition directing epithelial homeostasis and pre-invasive squamous cell carcinoma development J Pathol 229 2013 608 620
13. T. Nakamura, J. Hamuro, M. Takaishi, S. Simmons, K. Maruyama, and A. Zaffalon LRIG1 inhibits STAT3-dependent inflammation to maintain corneal homeostasis J Clin Invest 124 2014 385 397
14. J.M. Lee, B. Kim, S.B. Lee, Y. Jeong, Y.M. Oh, and Y.J. Song Cbl-independent degradation of Met: ways to avoid agonism of bivalent Met-targeting antibody Oncogene 33 2014 34 43
15. D.L. Shattuck, J.K. Miller, M. Laederich, M. Funes, H. Petersen, and K.L. Carraway LRIG1 is a novel negative regulator of the Met receptor and opposes Met and Her2 synergy Mol Cell Biol 27 2007 1934 1946
16. C. Simion, M.E. Cedano-Prieto, and C. Sweeney The LRIG family: enigmatic regulators of growth factor receptor signaling Endocr Relat Cancer 21 2014 R431 R443
17. H. Rafidi Lrig1 negative regulatory activity towards ErbB receptors is opposed by Lrig3 2014 University of California Davis
18. J. Nilsson, C. Vallbo, D. Guo, I. Golovleva, B. Hallberg, and R. Henriksson Cloning, characterization, and expression of human LIG1 Biochem Biophys Res Commun 284 2001 1155 1161
19. L. Mosyak, A. Wood, B. Dwyer, M. Buddha, M. Johnson, and A. Aulabaugh The structure of the Lingo-1 ectodomain, a module implicated in central nervous system repair inhibition J Biol Chem 281 2006 36378 36390
20. R.J. Coffey, G.D. Shipley, and H.L. Moses Production of transforming growth factors by human colon cancer lines Cancer Res 46 1986 1164 1169
21. K.B. Jensen, C.A. Collins, E. Nascimento, D.W. Tan, M. Frye, and S. Itami Lrig1 expression defines a distinct multipotent stem cell population in mammalian epidermis Cell Stem Cell 4 2009 427 439
22. Y. Wang, E.J. Poulin, and R.J. Coffey LRIG1 is a triple threat: ERBB negative regulator, intestinal stem cell marker and tumour suppressor Br J Cancer 108 2013 1765 1770
23. C.M. Heyworth, J. Hampson, T.M. Dexter, F. Walker, A.W. Burgess, and O. Kan Development of multipotential haemopoietic stem cells to neutrophils is associated with increased expression of receptors for granulocyte macrophage colony-stimulating factor: altered biological responses to GM-CSF during development Growth Factors 5 1991 87 98
24. P.G. Scott, P.A. McEwan, C.M. Dodd, E.M. Bergmann, P.N. Bishop, and J. Bella Crystal structure of the dimeric protein core of decorin, the archetypal small leucine-rich repeat proteoglycan Proc Natl Acad Sci U S A 101 2004 15633 15638
25. B. Kobe, and A.V. Kajava The leucine-rich repeat as a protein recognition motif Curr Opin Struct Biol 11 2001 725 732
26. H.M. Kim, S.C. Oh, K.J. Lim, J. Kasamatsu, J.Y. Heo, and B.S. Park Structural diversity of the hagfish variable lymphocyte receptors J Biol Chem 282 2007 6726 6732
27. C. Morlot, N.M. Thielens, R.B. Ravelli, W. Hemrika, R.A. Romijn, and P. Gros Structural insights into the Slit-Robo complex Proc Natl Acad Sci 104 2007 14923 14928
28. X.L. He, J.F. Bazan, G. McDermott, J.B. Park, K. Wang, and M. Tessier-Lavigne Structure of the Nogo receptor ectodomain: a recognition module implicated in myelin inhibition Neuron 38 2003 177 185
29. E. Seiradake, C.H. Coles, P.V. Perestenko, K. Harlos, R.A.J. McIlhinney, and A.R. Aricescu Structural basis for cell surface patterning through NetrinG-NGL interactions EMBO J 30 2011 4479 4488
30. A.F. Williams A year in the life of the immunoglobulin superfamily Immunol Today 8 1987 298 303
31. M.C. Lawrence, and P.M. Colman Shape complementarity at protein/protein interfaces J Mol Biol 234 1993 946 950
32. T. Sasaki, P.G. Knyazev, N.J. Clout, Y. Cheburkin, W. Göhring, and A. Ullrich Structural basis for Gas6-Axl signalling EMBO J 25 2006 80 87
33. I.C. King, and J.J. Catino Nonradioactive ligand binding assay for epidermal growth factor receptor Anal Biochem 188 1990 97 100
34. T.G. Johns, T.E. Adams, J.R. Cochran, N.E. Hall, P.A. Hoyne, and M.J. Olsen Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptor J Biol Chem 279 2004 30375 30384
35. M. Goetz, A. Ziebart, S. Foersch, M. Vieth, M.J. Waldner, and P. Delaney In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor Gastroenterology 138 2010 435 446
36. T.C. Elleman, T. Domagala, N.M. McKern, M. Nerrie, B. Lönnqvist, and T.E. Adams Identification of a determinant of epidermal growth factor receptor ligand-binding specificity using a truncated, high-affinity form of the ectodomain Biochemistry 40 2001 8930 8939
37. L. Bai, D. McEachern, C.Y. Yang, J. Lu, H. Sun, and S. Wang LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFalpha expression and receptor tyrosine kinase signaling Cancer Res 72 2012 1229 1238
38. L. Chang, R. Shi, T. Yang, F. Li, G. Li, and Y. Guo Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity J Exp Clin Cancer Res 32 2013 101
39. A.W. Hamburger The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies J Mammary Gland Biol Neoplasia 13 2008 225 233
40. I. Ljuslinder, I. Golovleva, R. Palmqvist, A. Oberg, R. Stenling, and Y. Jonsson LRIG1 expression in colorectal cancer Acta Oncol 46 2007 1118 1122
41. Y. Suzuki, H. Miura, A. Tanemura, K. Kobayashi, G. Kondoh, and S. Sano Targeted disruption of LIG-1 gene results in psoriasiform epidermal hyperplasia FEBS Lett 521 2002 67 71
42. T. Gaj, C.A. Gersbach, and C.F. Barbas ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering Trends Biotechnol 31 2013 397 405
43. Y. Xu, N.J. Kershaw, C.S. Luo, P. Soo, M.J. Pocock, and P.E. Czabotar Crystal structure of the entire ectodomain of gp130: insights into the molecular assembly of the tall cytokine receptor complexes J Biol Chem 285 2010 21214 21218
44. J.C. Carrington, and W.G. Dougherty A viral cleavage site cassette: identification of amino acid sequences required for tobacco etch virus polyprotein processing Proc Natl Acad Sci 85 1988 3391 3395
45. T.P. Hopp, K.S. Prickett, V.L. Price, R.T. Libby, C.J. March, and D.P. Cerretti A short polypeptide marker sequence useful for recombinant protein identification and purification Biotechnology 6 1988 1204 1210
46. F. Walker, J. deBlaquiere, and A.W. Burgess Translocation of pp60c-src from the plasma membrane to the cytosol after stimulation by platelet-derived growth factor J Biol Chem 268 1993 19552 19558
47. W. Kabsch Integration, scaling, space-group assignment and post-refinement Acta Crystallogr D Biol Crystallogr 66 2010 133 144
48. P.A. Karplus, and K. Diederichs Linking crystallographic model and data quality Science 336 2012 1030 1033
49. A.J. McCoy, R.W. Grosse-Kunstleve, P.D. Adams, M.D. Winn, L.C. Storoni, and R.J. Read Phaser crystallographic software J Appl Crystallogr 40 2007 658 674
50. P.D. Adams, P.V. Afonine, G. Bunkóczi, V.B. Chen, I.W. Davis, and N. Echols PHENIX: a comprehensive Python-based system for macromolecular structure solution Acta Crystallogr D Biol Crystallogr 66 2010 213 221
51. P. Emsley, B. Lohkamp, W. Scott, and K. Cowtan Features and development of Coot Acta Crystallogr D Biol Crystallogr 66 2010 486 501
52. O. Mayans, J. Wuerges, S. Canela, M. Gautel, and M. Wilmanns Structural evidence for a possible role of reversible disulphide bridge formation in the elasticity of the muscle protein titin Structure 9 2001 331 340
53. J. Sato, T. Kawamoto, A. Le, J. Mendelsohn, J. Polikoff, and G. Sato Biological effects in vitro of monoclonal antibodies to human epidermal growth factor receptors Mol Biol Med 1 1983 511 529
54. T.E. Adams, E.J. Koziolek, P.H. Hoyne, J.D. Bentley, L. Lu, and G. Lovrecz A truncated soluble epidermal growth factor receptor-Fc fusion ligand trap displays anti-tumour activity in vivo Growth Factors 27 2009 141 154
55. C.W. Tan, Y. Hirokawa, B.S. Gardiner, D.W. Smith, and A.W. Burgess Colon cryptogenesis: asymmetric budding PLoS One 8 2013 e78519